{"entity":{"type":"insider","cik":"0001405290","url":"/insider/0001405290","json_url":"/insider/0001405290.json","name":"Pham Quang X","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":18,"first":"2023-09-05","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Pham Quang X","source":"filing","n_filings":18,"first_seen":"2023-09-05","last_seen":"2026-07-01"}],"transactions":[{"id":5751974,"accession":"0001213900-26-074557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-074557","line_url":"/filing/0001213900-26-074557#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman and CEO), Ten percent owner","officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":3.03,"price_display":"3.03","price_state":"stated","total_value":22422.0,"total_display":"22,422.00","shares_owned_after":98589.0,"shares_owned_after_display":"98,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":6179117,"accession":"0001213900-26-072789","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-072789","line_url":"/filing/0001213900-26-072789#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9029.0,"shares_display":"9,029","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":27538.45,"total_display":"27,538.45","shares_owned_after":105989.0,"shares_owned_after_display":"105,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider"},{"id":6179114,"accession":"0001213900-26-072789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-072789","line_url":"/filing/0001213900-26-072789#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2127.0,"shares_display":"2,127","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":6381.0,"total_display":"6,381.00","shares_owned_after":115018.0,"shares_owned_after_display":"115,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider"},{"id":6236504,"accession":"0001213900-26-071578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-071578","line_url":"/filing/0001213900-26-071578#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2277.0,"shares_display":"2,277","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":7286.4,"total_display":"7,286.40","shares_owned_after":117145.0,"shares_owned_after_display":"117,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider"},{"id":6236500,"accession":"0001213900-26-071578","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-071578","line_url":"/filing/0001213900-26-071578#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9167.0,"shares_display":"9,167","price_per_share":3.55,"price_display":"3.55","price_state":"stated","total_value":32542.85,"total_display":"32,542.85","shares_owned_after":119422.0,"shares_owned_after_display":"119,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":6236489,"accession":"0001213900-26-070248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-070248","line_url":"/filing/0001213900-26-070248#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":513.0,"shares_display":"513","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":1621.08,"total_display":"1,621.08","shares_owned_after":128589.0,"shares_owned_after_display":"128,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":6236485,"accession":"0001213900-26-070248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-070248","line_url":"/filing/0001213900-26-070248#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3613.0,"shares_display":"3,613","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":11489.34,"total_display":"11,489.34","shares_owned_after":129102.0,"shares_owned_after_display":"129,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-18","scope":"insider"},{"id":5920880,"accession":"0001213900-26-068981","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-26-068981","line_url":"/filing/0001213900-26-068981#line-3","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3666.0,"shares_display":"3,666","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":13124.28,"total_display":"13,124.28","shares_owned_after":132715.0,"shares_owned_after_display":"132,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-15","scope":"insider"},{"id":5920878,"accession":"0001213900-26-068981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-068981","line_url":"/filing/0001213900-26-068981#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12996.0,"shares_display":"12,996","price_per_share":3.94,"price_display":"3.94","price_state":"stated","total_value":51204.24,"total_display":"51,204.24","shares_owned_after":136381.0,"shares_owned_after_display":"136,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-15","scope":"insider"},{"id":5920874,"accession":"0001213900-26-068981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-068981","line_url":"/filing/0001213900-26-068981#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1462.0,"shares_display":"1,462","price_per_share":4.12,"price_display":"4.12","price_state":"stated","total_value":6023.44,"total_display":"6,023.44","shares_owned_after":149377.0,"shares_owned_after_display":"149,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-15","scope":"insider"},{"id":6089775,"accession":"0001213900-26-067484","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-26-067484","line_url":"/filing/0001213900-26-067484#line-3","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":14735.0,"total_display":"14,735.00","shares_owned_after":150839.0,"shares_owned_after_display":"150,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-10","scope":"insider"},{"id":6089770,"accession":"0001213900-26-067484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-067484","line_url":"/filing/0001213900-26-067484#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12992.0,"shares_display":"12,992","price_per_share":4.06,"price_display":"4.06","price_state":"stated","total_value":52747.52,"total_display":"52,747.52","shares_owned_after":154339.0,"shares_owned_after_display":"154,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-10","scope":"insider"},{"id":6089766,"accession":"0001213900-26-067484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-067484","line_url":"/filing/0001213900-26-067484#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (Chairman, CEO and Interim CFO), Ten percent owner","officer_title":"Chairman, CEO and Interim CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5893.0,"shares_display":"5,893","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":25811.34,"total_display":"25,811.34","shares_owned_after":167331.0,"shares_owned_after_display":"167,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-10","scope":"insider"},{"id":6018741,"accession":"0001213900-26-065925","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-26-065925","line_url":"/filing/0001213900-26-065925#line-3","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2064.0,"shares_display":"2,064","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":9122.88,"total_display":"9,122.88","shares_owned_after":173224.0,"shares_owned_after_display":"173,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-05","scope":"insider"},{"id":6018738,"accession":"0001213900-26-065925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-065925","line_url":"/filing/0001213900-26-065925#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3898.0,"shares_display":"3,898","price_per_share":4.41,"price_display":"4.41","price_state":"stated","total_value":17190.18,"total_display":"17,190.18","shares_owned_after":175288.0,"shares_owned_after_display":"175,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider"},{"id":6018735,"accession":"0001213900-26-065925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-065925","line_url":"/filing/0001213900-26-065925#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2323.0,"shares_display":"2,323","price_per_share":4.26,"price_display":"4.26","price_state":"stated","total_value":9895.98,"total_display":"9,895.98","shares_owned_after":179186.0,"shares_owned_after_display":"179,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-05","scope":"insider"},{"id":6018732,"accession":"0001213900-26-064357","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-064357","line_url":"/filing/0001213900-26-064357#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":349.0,"shares_display":"349","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":1556.54,"total_display":"1,556.54","shares_owned_after":181509.0,"shares_owned_after_display":"181,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-02","filed_date":"2026-06-02","scope":"insider"},{"id":6018727,"accession":"0001213900-26-064357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-064357","line_url":"/filing/0001213900-26-064357#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":303.0,"shares_display":"303","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":1518.03,"total_display":"1,518.03","shares_owned_after":181858.0,"shares_owned_after_display":"181,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-02","scope":"insider"},{"id":5750230,"accession":"0001213900-26-062862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-26-062862","line_url":"/filing/0001213900-26-062862#line-3","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2989.0,"shares_display":"2,989","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":14735.77,"total_display":"14,735.77","shares_owned_after":182161.0,"shares_owned_after_display":"182,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-05-29","scope":"insider"},{"id":5887787,"accession":"0001213900-26-061167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-061167","line_url":"/filing/0001213900-26-061167#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1165.0,"shares_display":"1,165","price_per_share":5.69,"price_display":"5.69","price_state":"stated","total_value":6628.85,"total_display":"6,628.85","shares_owned_after":194924.0,"shares_owned_after_display":"194,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-26","scope":"insider"},{"id":5750229,"accession":"0001213900-26-062862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-062862","line_url":"/filing/0001213900-26-062862#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3298.0,"shares_display":"3,298","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":17413.44,"total_display":"17,413.44","shares_owned_after":185150.0,"shares_owned_after_display":"185,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-29","scope":"insider"},{"id":5750227,"accession":"0001213900-26-062862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-062862","line_url":"/filing/0001213900-26-062862#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6476.0,"shares_display":"6,476","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":37301.76,"total_display":"37,301.76","shares_owned_after":188448.0,"shares_owned_after_display":"188,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-29","scope":"insider"},{"id":5109209,"accession":"0001213900-25-103146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-103146","line_url":"/filing/0001213900-25-103146#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1315.0,"shares_display":"1,315","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":18396.85,"total_display":"18,396.85","shares_owned_after":196089.0,"shares_owned_after_display":"196,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-28","scope":"insider"},{"id":5109202,"accession":"0001213900-25-103146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-103146","line_url":"/filing/0001213900-25-103146#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1129.0,"shares_display":"1,129","price_per_share":14.03,"price_display":"14.03","price_state":"stated","total_value":15839.87,"total_display":"15,839.87","shares_owned_after":197404.0,"shares_owned_after_display":"197,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-24","filed_date":"2025-10-28","scope":"insider"},{"id":4992171,"accession":"0001213900-25-098719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-098719","line_url":"/filing/0001213900-25-098719#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":14.15,"price_display":"14.15","price_state":"stated","total_value":25470.0,"total_display":"25,470.00","shares_owned_after":198533.0,"shares_owned_after_display":"198,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-14","scope":"insider"},{"id":4992166,"accession":"0001213900-25-098719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-098719","line_url":"/filing/0001213900-25-098719#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":25236.0,"total_display":"25,236.00","shares_owned_after":200333.0,"shares_owned_after_display":"200,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-14","scope":"insider"},{"id":5070741,"accession":"0001213900-25-096241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-096241","line_url":"/filing/0001213900-25-096241#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":14.13,"price_display":"14.13","price_state":"stated","total_value":7065.0,"total_display":"7,065.00","shares_owned_after":202133.0,"shares_owned_after_display":"202,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4045583,"accession":"0001213900-25-094803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-094803","line_url":"/filing/0001213900-25-094803#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":881.0,"shares_display":"881","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":12342.81,"total_display":"12,342.81","shares_owned_after":202633.0,"shares_owned_after_display":"202,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-01","scope":"insider"},{"id":4045581,"accession":"0001213900-25-094803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-094803","line_url":"/filing/0001213900-25-094803#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419.0,"shares_display":"419","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":5870.19,"total_display":"5,870.19","shares_owned_after":203514.0,"shares_owned_after_display":"203,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":4299739,"accession":"0001213900-25-092557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-092557","line_url":"/filing/0001213900-25-092557#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6790.0,"shares_display":"6,790","price_per_share":14.09,"price_display":"14.09","price_state":"stated","total_value":95671.1,"total_display":"95,671.10","shares_owned_after":203933.0,"shares_owned_after_display":"203,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-25","filed_date":"2025-09-26","scope":"insider"},{"id":4299730,"accession":"0001213900-25-092557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-092557","line_url":"/filing/0001213900-25-092557#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2581.0,"shares_display":"2,581","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":36108.19,"total_display":"36,108.19","shares_owned_after":210723.0,"shares_owned_after_display":"210,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-24","filed_date":"2025-09-26","scope":"insider"},{"id":4533152,"accession":"0001213900-25-082819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-082819","line_url":"/filing/0001213900-25-082819#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1193.0,"shares_display":"1,193","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":16690.07,"total_display":"16,690.07","shares_owned_after":213304.0,"shares_owned_after_display":"213,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-08-29","scope":"insider"},{"id":4533147,"accession":"0001213900-25-082819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-082819","line_url":"/filing/0001213900-25-082819#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3836.0,"shares_display":"3,836","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":53665.64,"total_display":"53,665.64","shares_owned_after":214497.0,"shares_owned_after_display":"214,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-29","scope":"insider"},{"id":8117892,"accession":"0001213900-23-074336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-074336","line_url":"/filing/0001213900-23-074336#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":18200.0,"total_display":"18,200.00","shares_owned_after":3390000.0,"shares_owned_after_display":"3,390,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-06","scope":"insider"},{"id":8117889,"accession":"0001213900-23-074336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-074336","line_url":"/filing/0001213900-23-074336#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.8994,"price_display":"0.90","price_state":"stated","total_value":17988.0,"total_display":"17,988.00","shares_owned_after":3410000.0,"shares_owned_after_display":"3,410,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-06","scope":"insider"},{"id":8374822,"accession":"0001213900-23-073551","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-23-073551","line_url":"/filing/0001213900-23-073551#line-5","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.9291,"price_display":"0.93","price_state":"stated","total_value":18582.0,"total_display":"18,582.00","shares_owned_after":3330000.0,"shares_owned_after_display":"3,330,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8374819,"accession":"0001213900-23-073551","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-23-073551","line_url":"/filing/0001213900-23-073551#line-4","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.9222,"price_display":"0.92","price_state":"stated","total_value":18444.0,"total_display":"18,444.00","shares_owned_after":3350000.0,"shares_owned_after_display":"3,350,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8374816,"accession":"0001213900-23-073551","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-073551","line_url":"/filing/0001213900-23-073551#line-3","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.9318,"price_display":"0.93","price_state":"stated","total_value":9318.0,"total_display":"9,318.00","shares_owned_after":3310000.0,"shares_owned_after_display":"3,310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8374811,"accession":"0001213900-23-073551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-073551","line_url":"/filing/0001213900-23-073551#line-2","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.9168,"price_display":"0.92","price_state":"stated","total_value":9168.0,"total_display":"9,168.00","shares_owned_after":3360000.0,"shares_owned_after_display":"3,360,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8374807,"accession":"0001213900-23-073551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-073551","line_url":"/filing/0001213900-23-073551#line-1","is_derivative":false,"issuer_cik":"0001405290","issuer_name":"Cadrenal Therapeutics, Inc.","issuer_ticker":"CVKD","issuer_name_source":null,"issuer_url":"/issuer/0001405290","owner_cik":"0001405290","owner_name":"Pham Quang X","owner_url":"/insider/0001405290","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.8433,"price_display":"0.84","price_state":"stated","total_value":8433.0,"total_display":"8,433.00","shares_owned_after":3370000.0,"shares_owned_after_display":"3,370,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001937993","name":"Cadrenal Therapeutics, Inc.","url":"/issuer/0001937993","role":"Director, Officer (Chairman and CEO), Ten percent owner","n_filings":18,"first_seen":"2023-09-05","last_seen":"2026-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405290","retrieved_at":"2026-08-21T18:01:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}